Medicare Enrolled
Dr. Gabriel Menendez, M.D.
Neurology · Fort Myers, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Menendez from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Menendez?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Menendez
Dr. Gabriel Menendez is a neurology specialist in Fort Myers, FL, with 9 years of NPI registration. Based on federal Medicare data, Dr. Menendez performed 802 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Menendez received a total of $14,390 from 64 pharmaceutical and/or device companies across 789 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Menendez is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 9 years of NPI registration
▲ Top 36% volume in FL
$14,390 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 167123 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗802
Medicare services
Top 36% in FL for neurology
Not available
Unique patients (not deduplicated)
$93
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
375 | $84 | $161 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
101 | $86 | $156 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
78 | $112 | $261 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
69 | $158 | $309 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
45 | $53 | $121 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
40 | $42 | $155 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
29 | $115 | $244 |
| New patient office visit, complex (60-74 min) | 21 | $152 | $242 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
18 | $59 | $122 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 14 | $181 | $500 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
12 | $70 | $175 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$14,390
Total received (2021-2024)
Avg $3,597/year across 4 years
Top 22% in FL for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
64
Companies
789
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,357
2023
$5,846
2022
$5,144
2021
$1,042
Payments by company (2024)
UCB, Inc.
$259
ABBVIE INC.
$193
ANI Pharmaceuticals, Inc.
$185
PFIZER INC.
$173
Biogen, Inc.
$143
MDD US Operations, LLC
$122
Alexion Pharmaceuticals, Inc.
$116
TG Therapeutics, Inc.
$107
Lundbeck LLC
$102
SK Life Science, Inc.
$97
Neurocrine Biosciences, Inc.
$96
Sumitomo Pharma America, Inc.
$88
EMD Serono, Inc.
$86
Kyowa Kirin, Inc.
$85
ARGENX US, INC.
$71
Genentech USA, Inc.
$68
Alnylam Pharmaceuticals Inc.
$47
CATALYST PHARMACEUTICALS, INC.
$45
Lilly USA, LLC
$41
Teva Pharmaceuticals USA, Inc.
$38
Azurity Pharmaceuticals, Inc.
$37
Otsuka America Pharmaceutical, Inc.
$36
Acorda Therapeutics, Inc
$36
Novartis Pharmaceuticals Corporation
$35
Neurelis, Inc.
$31
SCILEX PHARMACEUTICALS INC.
$20
Top 3 companies account for 27.0% of 2024 payments
All-time payments by company (2021-2024) ›
ABBVIE INC.
$1,576
Biogen, Inc.
$1,437
UCB, Inc.
$965
EMD Serono, Inc.
$632
Alexion Pharmaceuticals, Inc.
$612
SK Life Science, Inc.
$473
IMPEL PHARMACEUTICALS INC.
$457
Novartis Pharmaceuticals Corporation
$446
ACADIA Pharmaceuticals Inc
$409
GENZYME CORPORATION
$402
Neurocrine Biosciences, Inc.
$392
PFIZER INC.
$387
Lundbeck LLC
$386
ANI Pharmaceuticals, Inc.
$379
Sumitomo Pharma America, Inc.
$347
TG THERAPEUTICS, INC.
$306
Amgen Inc.
$298
UPSHER-SMITH LABORATORIES LLC
$282
Biohaven Pharmaceutical Holding Company Ltd.
$261
Teva Pharmaceuticals USA, Inc.
$257
Janssen Pharmaceuticals, Inc
$241
Lilly USA, LLC
$212
Celgene Corporation
$207
Exeltis, USA Inc.
$186
Avanir Pharmaceuticals, Inc.
$171
Otsuka America Pharmaceutical, Inc.
$167
MDD US Operations, LLC
$163
ARGENX US, INC.
$162
Genentech USA, Inc.
$147
Scilex Pharmaceuticals Inc.
$127
Allergan, Inc.
$118
Amneal Pharmaceuticals LLC
$112
Biohaven Pharmaceuticals, Inc.
$110
Neurelis, Inc.
$108
TG Therapeutics, Inc.
$107
Kyowa Kirin, Inc.
$105
AstraZeneca Pharmaceuticals LP
$98
Azurity Pharmaceuticals, Inc.
$96
Sunovion Pharmaceuticals Inc.
$91
Avion Pharmaceuticals
$83
AbbVie Inc.
$79
Supernus Pharmaceuticals, Inc.
$73
MITSUBISHI TANABE PHARMA AMERICA, INC.
$66
Harmony Biosciences LLC
$62
Acorda Therapeutics, Inc
$53
BANNER LIFE SCIENCES, LLC
$49
CSL Behring
$48
Alnylam Pharmaceuticals Inc.
$47
CATALYST PHARMACEUTICALS, INC.
$45
Mallinckrodt Hospital Products Inc.
$41
Eisai Inc.
$33
Boston Scientific Corporation
$30
Amylyx Pharmaceuticals, Inc.
$26
Banner Life Sciences, LLC
$25
Catalyst Pharmaceuticals, Inc.
$24
Adamas Pharmaceuticals, Inc.
$24
LivaNova USA, Inc.
$23
Octapharma USA, Inc.
$22
Xeris Pharmaceuticals, Inc.
$21
SCILEX PHARMACEUTICALS INC.
$20
Grifols USA, LLC
$19
EISAI INC.
$19
Collegium Pharmaceutical, Inc.
$15
Currax Pharmaceuticals LLC
$14
Top 3 companies account for 27.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AGAMREE · AMYVID · ANDEXXA · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Apokyn · Austedo XR · BAFIERTAM · BOTOX · BRILINTA · BRIUMVI · Briviact · COMIRNATY · CONTRAVE · DAYBUE · DUOPA · Dhivy · ELIQUIS · ELYXYB - celecoxib · EMGALITY · FIRDAPSE · Fintepla · Fycompa · GOCOVRI · Gamunex-C · General - Therapies · Gocovri · HORIZANT · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · KEVEYIS · LYVISPAH · Leqembi · MAVENCLAD · MAYZENT · Mavenclad · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · Nuedexta · ONPATTRO · Ocrevus · Ongentys · PANZYGA · PAXLOVID · PLEGRIDY · PURIFIED CORTROPHIN GEL · Ponvory · QULIPTA · RADICAVA · RELYVRIO · REXULTI · RYTARY · Rystiggo · SKYCLARYS · SOLIRIS · Skyclarys · Soliris · TOSYMRA · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VUMERITY · VYEPTI · VYVGART HYTRULO · WAKIX · XCOPRI · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
182
County median income
$73,099
Nearest hospital to ZIP centroid (approximate)
GULF COAST MEDICAL CENTER LEE HEALTH
3.3 mi
3.3 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Menendez is a clinical cardiology specialist, with moderate Medicare volume.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Menendez experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Menendez performed 375 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Menendez receive payments from pharmaceutical companies?
Yes. Dr. Menendez received a total of $14,390 from 64 companies across 789 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Menendez's costs compare to other neurologists in Fort Myers?
Dr. Menendez's average Medicare payment per service is $93. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Menendez) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Fort Myers
Browse neurologists in Fort Myers ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in FL
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in FL
Which FL neurologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology